Stock traders pile into makers of cold medicines, antigen test kits as China’s shift from zero-Covid spurs demand

They are betting demand for these products will spike as China allows people to isolate at home and drops requirements for nucleic acid testing to encourage use of antigen test kits.

Read the original article at South China Morning Post